BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10642852)

  • 21. Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection.
    Harada S; Imaki T; Chikada N; Naruse M; Demura H
    Brain Res; 1999 Mar; 821(2):322-32. PubMed ID: 10064818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated methamphetamine treatment increases expression of TRPV1 mRNA in the frontal cortex but not in the striatum or hippocampus of mice.
    Tian YH; Lee SY; Kim HC; Jang CG
    Neurosci Lett; 2010 Mar; 472(1):61-4. PubMed ID: 20122992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
    Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the neuronal glutamate transporter EAAT3 in rat brain after exposure to methamphetamine.
    Kerdsan W; Thanoi S; Nudmamud-Thanoi S
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):275-8. PubMed ID: 22540959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex.
    Simões PF; Silva AP; Pereira FC; Marques E; Milhazes N; Borges F; Ribeiro CF; Macedo TR
    Ann N Y Acad Sci; 2008 Oct; 1139():232-41. PubMed ID: 18991869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of subchronic acrylamide exposure on the expression of neuronal and inducible nitric oxide synthase in rat brain.
    Kim K
    J Biochem Mol Toxicol; 2005; 19(3):162-8. PubMed ID: 15977197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of NADPH-diaphorase and expression of nNOS, N-methyl-D-aspartate receptor (NMDAR1) and non-NMDA glutamate receptor (GlutR2) genes in the neurons of the hippocampus after domoic acid-induced lesions in adult rats.
    Ananth C; Dheen ST; Gopalakrishnakone P; Kaur C
    Hippocampus; 2003; 13(2):260-72. PubMed ID: 12699333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide S attenuates methamphetamine-induced stereotyped behavior in rats.
    Li X; Jiang F; Yao K; Yang L; Gao X; Chen H; Wei X; Wu N; Zhou R; Yuan W; Zhang S
    Biochem Biophys Res Commun; 2020 Jun; 527(1):98-103. PubMed ID: 32446398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice.
    Wang J; Angulo JA
    Brain Res; 2011 Jan; 1369():131-9. PubMed ID: 21075091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of neuronal and inducible nitric oxide synthase in rat brain after subchronic administration of 3-monochloro-1,2-propanediol.
    Kim K
    Food Chem Toxicol; 2008 Mar; 46(3):955-60. PubMed ID: 18063462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of nitric oxide in morphine-induced c-Fos expression in the rat striatum.
    Harlan RE; Webber DS; Garcia MM
    Brain Res Bull; 2001 Jan; 54(2):207-12. PubMed ID: 11275410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine.
    Taraska T; Finnegan KT
    J Pharmacol Exp Ther; 1997 Feb; 280(2):941-7. PubMed ID: 9023310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral microglia mediate sleep/wake and neuroinflammatory effects of methamphetamine.
    Wisor JP; Schmidt MA; Clegern WC
    Brain Behav Immun; 2011 May; 25(4):767-76. PubMed ID: 21333736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
    Northrop NA; Yamamoto BK
    Neuropharmacology; 2013 Sep; 72():96-105. PubMed ID: 23643743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A selective regional response of cultured astrocytes to methamphetamine.
    Stadlin A; Lau JW; Szeto YK
    Ann N Y Acad Sci; 1998 May; 844():108-21. PubMed ID: 9668669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism.
    Horner KA; Westwood SC; Hanson GR; Keefe KA
    J Pharmacol Exp Ther; 2006 Oct; 319(1):414-21. PubMed ID: 16840646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of colocalization of neuronal nitric oxide synthase and somatostatin-like immunoreactivity in the mouse hippocampus: quantitative analysis with optical disector.
    Jinno S; Kosaka T
    Neuroscience; 2004; 124(4):797-808. PubMed ID: 15026120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.
    Thiriet N; Deng X; Solinas M; Ladenheim B; Curtis W; Goldberg SR; Palmiter RD; Cadet JL
    J Neurosci; 2005 Jun; 25(22):5273-9. PubMed ID: 15930374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.